Table 3 Interaction effects of PRS and nongenetic risk factors on AAO of PD.
From: Risk factors associated with age at onset of Parkinson’s disease in the UK Biobank
Model number | Variable | Estimate | SE | t value | P |
|---|---|---|---|---|---|
1 | Smoking | 0.9681 | 0.2524 | 3.8350 | 0.0001 |
PRS | −0.7556 | 0.1671 | −4.5210 | <0.0001 | |
Smoking × PRS | 0.5348 | 0.2487 | 2.1500 | 0.0316* | |
2 | Moderate or vigorous physical activate | 1.3308 | 0.2953 | 4.5060 | <0.0001 |
PRS | −0.0906 | 0.2373 | −0.3820 | 0.7027 | |
Moderate or vigorous physical activate × PRS | −0.5422 | 0.2897 | −1.8710 | 0.0614 | |
3 | NSAID=s intake | 0.6942 | 0.2687 | 2.5840 | 0.0098 |
PRS | −0.5125 | 0.1516 | −3.3800 | 0.0007 | |
NSAIDs intake × PRS | 0.0045 | 0.2680 | 0.0170 | 0.9866 | |
4 | EDS | −2.4980 | 0.2542 | −9.8260 | <0.0001 |
PRS | −0.3187 | 0.1580 | −2.0170 | 0.0438 | |
EDS × PRS | −0.4719 | 0.2507 | −1.8820 | 0.0599 | |
5 | Family history of PD | −1.7108 | 0.4356 | −3.9280 | <0.0001 |
PRS | −0.5699 | 0.1295 | −4.4010 | <0.0001 | |
Family history of PD × PRS | 0.8614 | 0.4439 | 1.9410 | 0.0524 |